Nykode Therapeutics ASA — Director's Dealing 2021

Mar 8, 2021

Mandatory notification of exercise of warrants and acquisition of shares by primary insiders

Mandatory notification of exercise of warrants and acquisition of shares by primary insiders

The following primary insiders/primary insider’s related parties have today bought 400,000 shares in Vaccibody AS at NOK 79.00 per share:

Datum AS 129,250

RASMUSSENGRUPPEN AS 129,250

Caaby AS 12,925

AS Tanja (Andenaesgruppen) 116,325

CF International ApS 12,250

Total 400,000

After the above transactions Jan Haudemann Andersen (board member) holds 40,263,050 shares (including 32,634,250 shares through Datum AS), Rasmussen Group of companies holds 33,936,750 shares (of which RASMUSSENGRUPPEN AS,in which Trygve Lauvdal (member of the VACCIBODY AS board) is an employee, owns 28,086,750), Christian Åbyholm (board member) through Caaby AS holds 1,995,895 shares and 100,000 warrants and Andenaesgruppen (through AS Tanja and Christiania Skibs AS) represented by Christian Åbyholm owns 17,870,575 shares and in addition Norda ASA represented by Christian Åbyholm owns 7,996,755 shares and Caspar Foghsgaard, Director Business Development holds 392,000 warrants and 468,250 shares through CF International ApS (a company wholly owned by Caspar Foghsgaard).

Due to a divorce process Primary insider CTO Mette Husbyn has exercised a total of 400,000 warrants with two expiry dates, first of December 20, 2022 and the second of December 31, 2022. 255,000 Vaccibody AS shares have been subscribed for at a strike price of NOK 2,50 per share and 145,000 Vaccibody AS shares have been subscribed for at a strike price of NOK 4,00 per share. The shares are borrowed from Datum AS. The shares are borrowed and sold to the market price of NOK 79.00 per share. Following the exercise of warrants Mette Husbyn holds 790,000 warrants.